|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 HKD | +6.33% |
|
+8.39% | -14.72% |
| Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
TOT BIOPHARM International Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 780.63 million compared to CNY 442.18 million a year ago. Net loss was CNY 37.76 million compared to CNY 49.92 million a year ago.
Basic loss per share from continuing operations was CNY 0.05 compared to CNY 0.08 a year ago. Diluted loss per share from continuing operations was CNY 0.05 compared to CNY 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.72% | 166M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED 
